Professional Documents
Culture Documents
Rhinovirus
Belong to the picornavirus family the smallest (pico) RNA
viruses (24-30 nm)
ssRNA virus
Acid-labile
Rhinovirus Capsid consists of 4 proteins VP1, VP2, VP3& VP4
At least 100 serotypes are known
Intercellular Adhesion Protein-1 (ICAM-1)
Receptor for most human rhinovirus serotypes
Rhinovirus bonded to
a CAM 1 receptor
Antibodies bonded
to a rhinovirus
Coronavirus
ssRNA Virus
Enveloped,
pleomorphic
morphology
2 serogroups:
OC43 and 229E
Transmission
Routes
Cold viruses may be transmitted
by three routes:
Large-particle droplets, which
can travel a short distance to
directly inoculate another
person
Small-particle aerosols, which
can travel longer distances
and deposit
directly in alveoli of other individuals
Secretion, which are transmitted by direct physical
contact
Rhinovirus
Higher rates occur in humid,
crowded conditions, as found in
nurseries, day care centers, and
schools, especially during cooler
months in temperate regions and
rainy season in tropical regions.
Pathogenesis
The offending virus invades the epithelial cells of
URT.
Inflammatory mediators are released.
They alter the vascular permeability and cause
tissue edema and stuffiness.
Stimulation of cholinergic nerves in the nose and
URT leads to increased mucus production
(rhinorrhea) and occasionally to bronchocontriction
Injury to cilia in the nasal epithelial cells may
decrease ciliary function and impair clearance of
nasal secretions.
Pathophysiology
Rhinoviruses are transmitted to
susceptible individuals by :
Direct contact
Aerosol particles
infecting both ciliated areas of the nose and nonciliated
areas of the nasopharynx through receptors, most
frequently ICAM-1 (found in high quantities in the posterior
nasopharynx).
Few cells are actually infected by the virus, and the
infection involves only a small portion of the epithelium.
Pathophysiology
Symptoms develop 1-2 days
after viral infection, peaking 2-4
days after inoculation, although
reports have described
symptoms as early as 2 hours
after inoculation with primary
symptoms 8-16 hours later.
Pathophysiology
Detectable histopathology causing the
Pathophysiology
Pathophysiology
The virus has a limited temperature
range in which it can grow (33-35C)
and cannot tolerate an acidic
environment.
Thus, finding the virus outside of the nasopharynx
is unlikely because of the acidic environment of
the stomach and the temperature elevation in both
the lower respiratory and gastrointestinal tracts.
VIRAL
INFECTION
OF NAZAL
CELLS
SNEEZING
SORE THROAT
Vascular
Dilatation
Increased
Vascular
Permeability
Tissue
Edema
Serum
Transduction
Increased
Mucus
Production
Sensitization
of Irritated of
Airways Receptors
NASAL OBSTRACTION
Cholinergic
Stimulation
RHINORRHEA
Bronchoconstriction
COUGH
Physical examination
Red nose with dripping nasal discharge may
be present.
Nasal mucous membranes have a
glistening, glassy appearance without
obvious erythema and edema.
Yellow or green nasal discharge does not
indicate bacterial infection because a large
number of white blood cells migrate to the
site of viral infection.
Physical Examination
If marked:
1. erythema, edema, exudates, or small
vesicles are observed in the oropharynx
2. conjunctivitis
3. polyps in the nasal mucosa occur, consider
other etiologies, including: adenovirus, herpes
Clinical characteristics
Incubation period 12-72 hours
Nasal obstruction, drainage,
sneezing, scratchy throat
Median duration 1 week but 25% can
last 2 weeks
Pharyngeal erythema is commoner
with adenovirus than with rhino or
coronavirus
Symptoms
Begins with a feeling of dryness and stuffiness in the
nasopharynx (nose)
Nasal secretions (usually clear and watery)
Watery eyes
Red and swollen nasal mucous membranes
Headache
Generalized tiredness
Chills (in severe cases)
If the pharynx and larynx
(throat) becomes involved:
Fever (in severe cases)
Sore throat
Hoarseness
Exhaustion (in severe cases)
Sever Symptoms
Mild Symptoms
Features
Influenza
Common
cold
Onset
Abrupt
More gradual
Fever
Common
Uncommon
Myalgia
Severe,
common
Severe,
common
Common
Uncommon
Severe,
common
Mild,
uncommon
Arthralgia
Anorexia
Headache
Uncommon
Uncommon
Cough (dry)
Common, severe
Mild to
moderate
Malaise
Severe
Mild
Fatigue,
weakness
More common
than with the
common cold;
lasts 2 to 3
weeks
Mild to
moderate
Stuffy nose
Occasional
Common
Sneezing
Occasional
Common
Sore throat
Occasional
Common
Complications
Laboratory Test
White cell count
or nasopharynx
Use of monoclonal antibodies
Polymerase chain reaction (PCR)
TREATMENT
MEDICATION
Drugs used in the symptomatic treatment
include:
TREATMENT
Rhinovirus infections are predominately mild
and self-limited:
TREATMENT
Development of effective antiviral medications has
VACCINATION
Because of the large number of rhinovirus
immunotypes and the inaccessibility of
the conserved region of the viral capsid
(the most likely effective site for targeting
a vaccine), no rhinovirus vaccine is on
the horizon.
PREVENTION
Because infection is spread by:
hand-to-hand contact,
autoinoculation,
possibly, aerosol particles,
emphasize appropriate hand washing,
avoidance of finger-to-eyes or finger-tonose contact, and use of nasal tissue.
Cough and sneeze into arm or tissue,
not into your hand
SUMMARY